Thomas O. Daniel's most recent trade in Gossamer Bio Inc was a trade of 115,000 Non-qualified stock option (Right to Buy) done . Disclosure was reported to the exchange on June 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 115,000 | 115,000 | - | - | Non-qualified stock option (Right to Buy) | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
Larimar Therapeutics Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 8,300 | 8,300 | - | - | Stock Option (right to buy) | |
Larimar Therapeutics Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 16,600 | 16,600 | - | - | Stock Option (right to buy) | |
Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 23,500 | 23,500 | - | - | Stock Option (right to buy) |